Lupin receives FDA nod for generic Atrovent Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Global pharma major Lupin Limited (Lupin) announced the launch of ipratropium bromide nasal solution (nasal spray), 0.03% and 0.06%, in the United States. Ipratropium bromide nasal solution (nasal ...

Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...

2022 was a very productive year for Amneal. The company successfully launched 26 new generic products. In the fourth quarter of 2022, Amneal launched eight new generic products, including clindamycin ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. <5yrs: not recommended. 5–11yrs: 2 sprays in each nostril 3 times daily. ≥12yrs: 2 sprays in each nostril 3–4 times daily. Epistaxis, dry mouth ...